Category: Scientific Advances
-
Insights Into Key Molecular Process Underlying Many Cancers
A paper published in Molecular Cell provides new insight into a protein complex called COMPASS and its function during histone methylation, a key modification that regulates gene expression.
-
Uncovering Metabolism’s Clockwork
Joseph Bass, MD, PhD, chief of Endocrinology, Metabolism and Molecular Medicine, focuses his research on illuminating how the body’s clocks regulate feeding behavior and glucose metabolism, and identifies how disruptions in that overarching circadian system play a role in metabolic disease.
-
Insights Into Enzyme Targets Could Lead to New Cancer Therapies
Northwestern Medicine scientists have identified the unique targets of two enzymes that activate ubiquitination, a key modification of proteins that controls a variety of cellular processes.
-
Student Uncovers a Potential Path to Treating Age-Related Memory Loss
A Northwestern Medicine study, led by a PhD student, found that overexpressing a protein called CREB improved memory impairments in aged rats.
-
Scientists Identify Structural Changes in Herpesvirus Fusion
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
-
Engineering Nanomaterials to Deliver Precise Treatments for Heart Disease
Northwestern Medicine scientists have demonstrated an enhanced approach to targeting a type of inflammatory cell involved in atherosclerosis.
-
2016 in Scientific Imagery
From 3-D printed hyperelastic bones to the nuclear membrane of immature red blood cells, scientific images bring to life the range of research published by Feinberg faculty and students in 2016.
-
Investigating the Role of MicroRNAs in Regulating Stem Cells of the Eye
Northwestern Medicine scientists showed how a microRNA family regulates aspects of autophagy and macropinocytosis in the stem cell–enriched limbal epithelium of the eye.
-
New Insights Into Signaling Pathway Could Lead to Novel Therapies for Neurological Disorders
Northwestern Medicine scientists have demonstrated an alternate method of signaling used by proteins called group I metabotropic glutamate receptors, a finding that could be used to develop novel drug treatments for many neurological disorders.
-
A Quest to Lengthen Quality Life
Northwestern Medicine scientists are exploring a new drug that could make people healthier for longer by slowing the aging process.
